Home > Back to Publisher > Report Information

Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth

GBI Research
February 14, 2012
213 Pages - SKU: XGBR6820253

Abstract Table of Contents Search inside this report Related Reports

Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth

Summary

GBI Research’s report, “Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth” provides key data, information and analysis on the global cardiovascular devices market. The report provides the market landscape, competitive landscape and market trend information on ten cardiovascular devices market categories: cardiac rhythm management, interventional cardiology, peripheral vascular devices, cardiovascular surgery, prosthetic heart valves, external defibrillators, electrophysiology, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices and cardiac assist devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the cardiovascular devices market during the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
The market size of ten cardiovascular devices market categories: cardiac rhythm management, cardiology, interventional, peripheral vascular devices, cardiovascular surgery, prosthetic heart valves, external defibrillators, electrophysiology, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices and cardiac assist devices.
Annualized market revenue data from 2003 to 2010, forecast forward for 7 years to 2017.
Qualitative analysis of key market trends, market drivers and restraints by each category within the cardiovascular devices market.
The report also covers information on the leading market players, the competitive landscape, and the leading technologies.
Key players covered include: Medtronic, Inc., Boston Scientific Corporation, St. Jude Medical, Inc., Abbott Laboratories, Cordis Corporation, Sorin Group, Terumo Corporation, C.R. Bard, Inc., Edwards Lifesciences Corporation, BIOTRONIK SE & Co. KG, and Philips Healthcare

Reasons to buy

Develop business strategies by understanding the trends and developments that are driving the cardiovascular devices market globally.
Design and develop your product development, marketing and sales strategies.
Exploit M&A opportunities by identifying market players with the most innovative pipeline.
Develop market-entry and market expansion strategies.
Identify key players best positioned to take advantage of emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying the products most likely to ensure a robust return.
What’s the next big thing in the cardiovascular devices market landscape? Identify, understand and capitalize.
Make more informed business decisions with the aid of insightful and in-depth analysis of the global cardiovascular devices market and the factors shaping it.

Additional Information

GBI Research’s report, “Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth” provides key data, information and analysis on the global cardiovascular devices market. The report provides the market landscape, competitive landscape and market trend information on ten cardiovascular devices market categories: cardiac rhythm management, interventional cardiology, peripheral vascular devices, cardiovascular surgery, prosthetic heart valves, external defibrillators, electrophysiology, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices and cardiac assist devices. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and provides a detailed analysis of the pipeline products in each category. The report also reviews details about important merger and acquisition deals that have taken place in the cardiovascular devices market during the past four years. The report is compiled using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The Global Cardiovascular Devices Market is Forecast to Reach $43.4 Billion by 2017

The global cardiovascular devices market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 4% during the period 2010-2017 to reach $43.4 billion by 2017.

The cardiovascular devices market will be driven by an increase in the incidence of Cardiovascular Diseases (CVDs), an increasing elderly population across the globe, an increase in risk factors such as diabetes, smoking, and hypertension leading to CVDs and the greater adoption of technological advancements. According to the World Health Organization (WHO), CVDs are the leading causes of death and disability in the world. In 2008, CVDs were responsible for 17.3 million deaths. Heart attacks were responsible for 7.3 million and strokes were responsible for 6.2 million deaths.

According to the WHO, there will be about 23.6 million deaths from CVD by 2030, primarily from heart disease and stroke. The incidence of CVD is expected to increase further in future due to an increase in behavioral risk factors, such as smoking, poor nutrition, lack of physical movement, type-A personality, high alcohol consumption and drug abuse. Behavioral risk factors are responsible for about 80% of coronary heart disease and cerebrovascular disease.

Cardiac Rhythm Management Devices is the Largest Category in the Global Cardiovascular Devices Market

The Cardiac Rhythm Management (CRM) devices category was the largest category in the global cardiovascular devices market in 2010. The CRM market accounted for about 35% of the overall cardiovascular devices market.

The global CRM market was valued at $11.39 billion in 2010 and is forecast to grow at a CAGR of 4% to reach $15.16 billion in 2017. Within this category ‘pacemakers’ was the largest segment. The market for CRM has grown over the past five decades due to improved device function, advances in technology and implantation techniques, and a rapidly expanding set of clinical indications.

Technological Advances and Minimally Invasive Procedures to Drive the Cardiovascular Devices Market

The innovations in technology and design of cardiovascular devices in past the few years have led to an increase in the demand for cardiovascular devices. The modern day devices such as Magnetic Resonance Imaging (MRI) compatible pacemakers will increase the demand for pacemakers as the majority of patients require an MRI after implantation. Other innovative products such as artificial hearts, bioresorbable stents, tissue heart valves and heart rhythm devices with wireless telemetry features are driving the cardiovascular devices market. Along with these innovations, cardiovascular procedures which are minimally invasive are also resulting in the growth of cardiovascular procedure volumes. Procedures such as balloon angioplasty and Percutaneous Coronary Intervention (PCI) are minimally invasive techniques. Transcatheter heart valve replacement is a minimally invasive technique for heart valve replacement. Heart Valve surgeries, including valve repairs and valve replacements, are the most common minimally invasive heart surgery procedures.

Procedures such as Minimally Invasive Direct Coronary Artery Bypass Graft (MIDCAB), Port-Access Coronary Artery Bypass (also referred to as PACAB or PortCAB), Off-Pump Coronary Artery Bypass (OPCAB), Robotic Assisted Coronary Artery Bypass (RACAB) and Totally Endoscopic Coronary Artery Bypass Graft (TECAB) are minimally invasive procedures. Procedures such as balloon angioplasty and Percutaneous Coronary Intervention (PCI) are minimally invasive techniques. Endovascular Aortic Repair (EVAR) is a procedure to treat abdominal aneurysms endovascularly and is minimally invasive. Transcatheter heart valve replacement is a minimally invasive technique for heart valve replacement. Heart valve surgeries, including valve repairs and valve replacements, are the most common minimally invasive heart surgery procedures. Other procedures such as epicardial lead placement: placement of leads for biventricular pacemakers (cardiac resynchronization therapy), transmyocardial laser revascularization and minimally invasive radiofrequency ablation for atrial fibrillation are also minimally invasive procedures.

The advantages of minimally invasive surgeries include less pain, lower risk of infection, reduced blood loss, reduced Intensive Care Unit (ICU) and hospital stays, improved postoperative pulmonary function, fast recovery and improved quality of life have increased the patient satisfaction. These advantages are driving younger patients to undergo surgery as they need less recuperation time and can get back to work sooner. The minimally invasive techniques are also advantageous to the elderly and high risk patients as there are fewer traumas associated with the procedure and a lower risk of infection.

Medtronic, Inc. to Dominate Global Cardiovascular Devices Market

Medtronic holds the leading market position with 23% of the cardiovascular devices market share It has a wide product portfolio with products in pacing systems and implantable cardiac rhythm devices. The acquisition of Invatec and two affiliated companies, Fogazzi and Krauth Cardiovascular, as well as the $370m purchase of ATS Medical Inc. in 2010, played an important role in maintaining Medtronic’s market share in the cardiovascular devices market. The Invatech deal broadened the product portfolio of Medtronic and enabled it to market drug-eluting balloons covering the coronaries and lower extremities, while the ATS merger enabled the company to provide open-pivot bileaflet mechanical and 3f pericardial valve technology to cardiac surgeons.

Other major companies in the industry are Boston scientific with a 15% market share, St. Jude Medical with 11% and Abbott laboratories with 9%. The cardiovascular devices market is dominated by these four major companies, which together capture a 59% market share. The market is fragmented with many smaller companies operating in the market. These smaller companies include Cordis, Terumo and Sorin. Companies such as Edwards LifeSciences, C.R. Bard, Biosense Webster, Philips Healthcare and Biotronik also have very good product portfolios for specific categories in the cardiovascular devices market.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 GBI Research Guidance
3 Global Cardiovascular Devices - Market Characterization: 3.1 Global Cardiovascular Devices Market, Revenue ($bn), 2003-2010; 3.2 Global Cardiovascular Devices Market, Revenue ($bn), 2010-2017; 3.3 Global Cardiovascular Devices Market, Key Company Shares (%), 2010; 3.4 Global Cardiovascular Devices Market, Key Trends; 3.5 Global Cardiovascular Devices, Market Dynamics
4 Global Cardiovascular Devices Market - Category Analysis and Forecasts: 4.1 Cardiac Rhythm Management Devices; 4.2 Cardiac Rhythm Management - Market Dynamics; 4.3 Interventional Cardiology; 4.4 Interventional Cardiology - Market Dynamics; 4.5 Peripheral Vascular Devices; 4.6 Peripheral Vascular Devices - Market Dynamics; 4.7 Cardiovascular Surgery Devices; 4.8 Cardiovascular Surgery Devices - Market Dynamics; 4.9 Prosthetic Heart Valves; 4.10 Prosthetic Heart Valves - Market Dynamics; 4.11 External Defibrillators; 4.12 External Defibrillators - Market Dynamics; 4.13 Electrophysiology; 4.14 Electrophysiology - Market Dynamics; 4.15 Cardiovascular Monitoring and Diagnostic Devices; 4.16 Cardiovascular Monitoring and Diagnostic Devices - Market Dynamics; 4.17 Cardiac Assist Devices; 4.18 Cardiac Assist Devices - Market Dynamics; 4.19 Cardiovascular Prosthetic Devices; 4.20 Cardiovascular Prosthetic Devices - Market Dynamics
5 Global Cardiovascular Devices Market - Country Analysis and Forecasts: 5.1 Cardiovascular Devices Market - Cross-Country Analysis; 5.2 Historic (2003-2010) and Forecast (2010-2017) Revenue, By Country
6 Global Cardiovascular Devices Market - Competitive Assessment: 6.1 Boston Scientific Corporation; 6.2 Medtronic, Inc; 6.3 St. Jude Medical, Inc.; 6.4 Abbott Laboratories; 6.5 Cordis; 6.6 Terumo Corporation; 6.7 Sorin Group; 6.8 Phillips Healthcare; 6.9 Edwards Lifesciences Corporation; 6.10 C.R. Bard, Inc.; 6.11 Biosense Webster, Inc.; 6.12 BIOTRONIK SE & Co. KG
7 Global Cardiovascular Devices Market - Product Pipeline Analysis: 7.1 Interventional Cardiology; 7.2 Interventional Cardiology - List of Pipeline Products; 7.3 Profiles of Key Pipeline Products - Interventional cardiology; 7.4 Peripheral Vascular Devices; 7.5 Peripheral Vascular Devices - List of Pipeline Products; 7.6 Profiles of Key Pipeline Products - Peripheral Vascular Devices; 7.7 Cardiovascular Monitoring and Diagnostic Devices; 7.8 Cardiovascular Monitoring and Diagnostic Devices - List of Pipeline Products; 7.9 Profiles of Key Pipeline Products - Cardiovascular Monitoring and Diagnostic Devices; 7.10 Cardiac Assist Devices; 7.11 Cardiac Assist Devices - List of Pipeline Products; 7.12 Profiles of Key Pipeline Products - Cardiac Assist Devices; 7.13 Electrophysiology; 7.14 Electrophysiology - List of Pipeline Products; 7.15 Profiles of Key Pipeline Products - Electrophysiology; 7.16 Prosthetic Heart Valves; 7.17 Prosthetic Heart Valves - List of Pipeline Products; 7.18 Profiles of Key Pipeline Products - Prosthetic Heart Valves; 7.19 Cardiovascular Surgery Devices; 7.20 Cardiovascular Surgery Devices - List of Pipeline Products; 7.21 Profiles of Key Pipeline Products - Cardiac Surgery Devices; 7.22 Cardiac Rhythm Management; 7.23 Cardiac Rhythm Management - List of Pipeline Products; 7.24 Profiles of Key Pipeline products - Cardiac Rhythm Devices; 7.25 Cardiovascular Prosthetic Devices; 7.26 Cardiovascular Prosthetic Devices - List of Pipeline Products; 7.27 Profiles of Key Pipeline Products - Cardiovascular Prosthetic Devices; 7.28 External Defibrillators; 7.29 External Defibrillators: List of Pipeline Products; 7.30 Profiles of Key Pipeline Products - External Defibrillators
8 Global Cardiovascular Devices Market - Consolidation Landscape: 8.1 Number of Deals, 2007-2011; 8.2 Key Deals in 2007-2011(Q1-Q3)
9 Appendix: 9.1 Definitions; 9.2 Acronyms; 9.3 Sources; 9.4 Research Methodology; 9.5 Contact Us; 9.6 Disclaimer
1.1 List of Tables: Table 1: Cardiovascular Devices Market, Global, Revenue ($bn), 2003-2010; Table 2: Cardiovascular Devices Market, Global, Revenue ($bn), 2010-2017; Table 3: Cardiovascular Devices Market, Global, Key Company Revenues ($m), 2010; Table 4: Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2003-2010; Table 5: Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2010-2017; Table 6: Interventional Cardiology Devices Market, Global, Revenue ($m), 2003-2010; Table 7: Interventional Cardiology Devices Market, Global, Revenue ($m), 2010-2017; Table 8: Interventional Cardiology Devices Market, Global, Key Company Revenues ($m), 2010; Table 9: Peripheral Vascular Devices Market, Global, Revenue ($m), 2003-2010; Table 10: Peripheral Vascular Devices Market, Global, Revenue ($m), 2010-2017; Table 11: Peripheral Vascular Devices Market, Global, Key Company Revenues ($m), 2010; Table 12: Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2003-2010; Table 13: Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2010-2017; Table 14: Cardiovascular Surgery Devices Market, Global, Key Company Revenues ($m), 2010; Table 15: Prosthetic Heart Valves Market, Global, Revenue ($m), 2003-2010; Table 16: Prosthetic Heart Valves Market, Global, Revenue ($m), 2010-2017; Table 17: Prosthetic Heart Valves Devices Market, Global, Key Company Revenues ($m), 2010; Table 18: External Defibrillators Devices Market, Global, Revenue ($m), 2003-2010; Table 19: External Defibrillators Devices Market, Global, Revenue ($m), 2010-2017; Table 20: External Defibrillators Devices Market, Global, Key Company Revenues ($m), 2010; Table 21: Electrophysiology, Global, Revenue ($m), 2003-2010; Table 22: Electrophysiology, Global, Revenue ($m), 2010-2017; Table 23: Electrophysiology, Global, Key Company Revenues ($m), 2010; Table 24: Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2003-2010; Table 25: Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2010-2017; Table 26: Cardiovascular Monitoring and Diagnostic Devices Market, Global, Key Company Revenues ($m), 2010; Table 27: Cardiac Assist Devices, Global, Market, Revenue ($m), 2003-2010; Table 28: Cardiac Assist Devices, Global, Market, Revenue ($m), 2010-2017; Table 29: Cardiac Assist Devices Market, Global, Key Company Revenues ($m), 2010; Table 30: Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2003-2010; Table 31: Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2010-2017; Table 32: Cardiovascular Prosthetic Devices Market, Global, Key Company Revenues ($m), 2010; Table 33: Cardiovascular Devices Market, Global, Cross Country Analysis, CAGR (%), 2003-2017; Table 34: Cardiovascular Devices Market, The US, Revenue ($m), 2003-2010; Table 35: Cardiovascular Devices Market, The US, Revenue ($m), 2010-2017; Table 36: Cardiovascular Devices Market, Canada, Revenue ($m), 2003-2010; Table 37: Cardiovascular Devices Market, Canada, Revenue ($m), 2010-2017; Table 38: Cardiovascular Devices Market, The UK, Revenue ($m), 2003-2010; Table 39: Cardiovascular Devices Market, The UK, Revenue ($m), 2010-2017; Table 40: Cardiovascular Devices Market, Germany, Revenue ($m), 2003-2010; Table 41: Cardiovascular Devices Market, Germany, Revenue, ($m), 2010-2017; Table 42: Cardiovascular Devices Market, France, Revenue ($m), 2003-2010; Table 43: Cardiovascular Devices Market, France, Revenue $m), 2010-2017; Table 44: Cardiovascular Devices Market, Italy, Revenue ($m), 2003-2010; Table 45: Cardiovascular Devices Market, Italy, Revenue ($m), 2010-2017; Table 46: Cardiovascular Devices Market, Spain, Revenue ($m), 2003-2010; Table 47: Cardiovascular Devices Market, Spain, Revenue, ($m), 2010-2017; Table 48: Cardiovascular Devices Market, Japan, Revenue, ($m), 2003-2010; Table 49: Cardiovascular Devices Market, Japan, Revenue, ($m), 2010-2017; Table 50: Cardiovascular Devices Market, China, Revenue ($m), 2003-2010; Table 51: Cardiovascular Devices Market, China, Revenue, ($m), 2010-2017; Table 52: Cardiovascular Devices Market, India, Revenue ($m), 2003-2010; Table 53: Cardiovascular Devices Market, India, Revenue ($m), 2010-2017; Table 54: Cardiovascular Devices Market, Australia, Revenue ($m), 2003-2010; Table 55: Cardiovascular Devices Market, Australia, Revenue ($m), 2010-2017; Table 56: Cardiovascular Devices Market, Brazil, Revenue ($m), 2003-2010; Table 57: Cardiovascular Devices Market, Brazil, Revenue ($m), 2010-2017; Table 58: Interventional Cardiology Market, Global, Pipeline Products Summary, 2011; Table 59: Interventional Cardiology, Pipeline Product Summary, 2011-1; Table 60: Interventional Cardiology, Pipeline Product Summary, 2011-2; Table 61: Interventional Cardiology, Pipeline Product Summary, 2011-3; Table 62: Interventional Cardiology, Pipeline Product Summary, 2011-4; Table 63: Interventional Cardiology, Pipeline Product Summary, 2011-5; Table 64: Interventional Cardiology, Pipeline Product Summary, 2011-6; Table 65: Interventional Cardiology, Pipeline Product Summary, 2011-7; Table 66: Interventional Cardiology, Pipeline Product Summary, 2011-8; Table 67: Absorb, Product Status, 2011; Table 68: AVJ-09-385, Product Status, 2011; Table 69: Bifurcated DES, Product Status, 2011; Table 70: OMEGA Platinum Chromium Coronary Stent, Product Status, 2011; Table 71: Avion Bifurcation RX2, Product Status, 2011; Table 72: T NC Zulu PTCA, Product Status, 2011; Table 73: FiberHalo SRM Pre-Dilation Angioplasty Catheter, Product Status, 2011; Table 74: Wrist Artery Guidewire, Product Status, 2011; Table 75: Coronary Guidewire, Product Status, 2011; Table 76: FastSeal Bioabsorbable Vascular Access Closure System, Product Status, 2011; Table 77: jLab System + 3.0 Software, Product Status, 2011; Table 78: VALET Micro-Catheter, Product Status, 2011; Table 79: IN.PACT Falcon PTCA, Product Status, 2011; Table 80: Peripheral Vascular Devices Market, Global, Pipeline Products Summary, 2011; Table 81: Peripheral Vascular Devices, Pipeline Product Summary, 2011-1; Table 82: Peripheral Vascular Devices, Pipeline Product Summary, 2011-2; Table 83: Peripheral Vascular Devices, Pipeline Product Summary, 2011-3; Table 84: Peripheral Vascular Devices, Pipeline Product Summary, 2011-4; Table 85: Peripheral Vascular Devices, Pipeline Product Summary, 2011-5; Table 86: Peripheral Vascular Devices, Pipeline Product Summary, 2011-6; Table 87: Peripheral Vascular Devices, Pipeline Product Summary, 2011-7; Table 88: WallFlex Biliary RX Fully Covered Stent - Benign Biliary Strictures, Product Status, 2011; Table 89: Pulsar-80 Stent, Product Status, 2011; Table 90: Amplatzer AAA (Abdominal Aortic Aneurysms) Vascular Graft, Product Status, 2011; Table 91: INCRAFT AAA (Abdominal Aortic Aneurysm) Stent Graft, Product Status, 2011; Table 92: POWERFLEX Pro PTA Balloon, Product Status, 2011; Table 93: Next Generation Stent Graft, Product Status, 2011; Table 94: Fusion Vascular Access Graft, Product Status, 2011; Table 95: Bard Denali Retrievable Inferior Vena Cava Filter System, Product Status, 2011; Table 96: Embrella Embolic Deflector System, Product Status, 2011; Table 97: Skipper Deep, Product Status, 2011; Table 98: Passeo-18 Lux, Product Status, 2011; Table 99: Boston Drug Eluting Balloon, Product Status, 2011; Table 100:Cardiovascular Monitoring and Diagnostic Devices Market, Global, Pipeline Products Summary, 2011; Table 101:Cardiovascular Monitoring and Diagnostic Devices, Pipeline Product Summary, 2011-1; Table 102:Cardiovascular Monitoring and Diagnostic Devices, Pipeline Product Summary, 2011-2; Table 103:Cardiovascular Monitoring and Diagnostic Devices, Pipeline Product Summary, 2011-3; Table 104: 24/7 WiFi ECG (electrocardiogram) Monitor, Product Status, 2011; Table 105: Heartscape 3D ECG System with 80-Lead Vest, Product Status, 2011; Table 106: Aingeal Wireless Holter Monitor, Product Status, 2011; Table 107: Diagnostic Test - Pulmonary Arterial Hypertension, Product Status, 2011; Table 108: Blue Scale, Product Status, 2011; Table 109: Cardiac Assist Devices Market, Global, Pipeline Products Summary, 2011; Table 110: Cardiac Assist Devices, Pipeline Product Summary, 2011-1; Table 111: Cardiac Assist Devices, Pipeline Product Summary, 2011-2; Table 112: Cardiac Assist Devices, Pipeline Product Summary, 2011-3; Table 113: 50cc Total Artificial Heart, Product Status, 2011; Table 114: AbioCor II, Product Status, 2011; Table 115: DuraHeart II, Product Status, 2011; Table 116: Percutaneous Heart Pump, Product Status, 2011; Table 117: Electrophysiology Market, Global, Pipeline Products Summary, 2011; Table 118: Electrophysiology, Pipeline Product Summary, 2011-1; Table 119: Electrophysiology, Pipeline Product Summary, 2011-2; Table 120: Electrophysiology, Pipeline Product Summary, 2011-3; Table 121: Lesion Assessment Device, Product Status, 2011; Table 122: ENCOMPASS, Product Status, 2011; Table 123: ThermoCool SmartTouch Contact Force Sensing Catheter, Product Status, 2011; Table 124: Multi-Array Septal Catheter, Product Status, 2011; Table 125: CARTO 3 V3 Navigation System, Product Status; Table 126: Integrated X-ray and Robotic Catheter System, Product Status, 2011; Table 127: Prosthetic Heart Valves Market, Global, Pipeline Products Summary, 2011; Table 128: Prosthetic Heart Valves, Pipeline Product Summary, 2011, Table-1; Table 129: Prosthetic Heart Valves, Pipeline Product Summary, 2011, Table-2; Table 130: Prosthetic Heart Valves, Pipeline Product Summary, 2011, Table-3; Table 131: Freedom Solo, Product Status, 2011; Table 132: Closed-Chest Aortic Tissue Valve, Product Status, 2011; Table 133: Synthetic Tri-Leaflet Minimally Invasive Heart Valve, Product Status, 2011; Table 134: ATS Open Pivot Heart Valve - ForceField, Product Status, 2011; Table 135: 26 Millimeter CoreValve System, Product Status, 2011; Table 136: Lotus Valve System, Product Status, 2011; Table 137: Next Generation Transcatheter Heart Valve, product Status, 2011; Table 138:Cardiovascular Surgery Devices Market, Global, Pipeline Products Summary, 2011; Table 139: Cardiovascular Surgery Devices, Pipeline Product Summary, 2011-1; Table 140: Cardiovascular Surgery Devices, Pipeline Product Summary, 2011-2; Table 141: LinOx Oxygenator, Product Status, 2011; Table 142: MI-Cath Infusion Catheter, Product Status, 2011; Table 143: Apica Heart Surgery System, Product Status, 2011; Table 144: ApiCor, Product Status, 2011; Table 145: Bcare5+ Multiparametric ILBM, Product Status, 2011; Table 146: CP5, Product Status, 2011; Table 147: ClariVein - Vascular Ablation, Product Status, 2011; Table 148: Cardiac Rhythm Management Market, Global, Pipeline Products Summary, 2011; Table 149: Cardiac Rhythm Management Devices, Pipeline Product Summary, 2011; Table 150: Accent MRI Pacemaker, Product Status, 2011; Table 151: Advisa DR MRI SureScan Pacing System, Product Status, 2011; Table 152: INGENIO 2 PG - MICS, Product Status, 2011; Table 153: INCEPTA Cardiac Resynchronization Therapy Defibrillator, Product Status 2011; Table 154: Promote Quadra, Product Status, 2011; Table 155: AnalyST Implantable Cardioverter Defibrillator, Product Status, 2011; Table 156: Paradym DR, Product Status, 2011; Table 157:Cardiovascular Prosthetic Devices Market, Global, Pipeline Products Summary, 2011; Table 158: Cardiovascular Prosthetic Devices, Pipeline Product Summary, 2011; Table 159: Cardiovascular Prosthetic Devices, Pipeline Product Summary, 2011; Table 160: MitraClip Device, Product Status, 2011; Table 161: HAART 300 Annuloplasty Device, Product Status, 2011; Table 162: Premere PFO Closure System, Product Status; Table 163: Amplatzer PFO(Cryptogenic Strokes, Product Status, 2011; Table 164: External Defibrillators Market, Global, Pipeline Products Summary, 2011; Table 165: External Defibrillators, Pipeline Product Summary, 2011; Table 166: Next Generation SMART AED, Product Status, 2011; Table 167:Cardiovascular Devices Market, Mergers and Acquisitions, Number of Deals, Global, 2007-2010; Table 168:.Cardiovascular Devices Market, Mergers and Acquisitions, Global, 2010; Table 169: Cardiovascular Devices Market, Mergers and Acquisitions, Global, 2009; Table 170: Cardiovascular Devices Market, Mergers and Acquisitions, Global, 2008; Table 171: Cardiovascular Devices Market, Mergers and Acquisitions, Global, 2007
1.2 List of Figures: Figure 1: Cardiovascular Devices Market, Global, Revenue ($bn), 2003-2010; Figure 2: Cardiovascular Devices Market, Global, Revenue ($bn), 2010-2017; Figure 3: Cardiovascular Devices Market, Global, Key Company Shares (%), 2010; Figure 4: Cardiovascular Devices Market, Major Deals by Volume, 2010-2011; Figure 5: Population, Global, Aged 65 and Above (%), 2010 and 2050; Figure 6: Ranking of Selected Cardiovascular Risk Factors; Figure 7: Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2003-2010; Figure 8: Cardiac Rhythm Management Devices Market, Global, Revenue ($m), 2010-2017; Figure 9: Cardiac Rhythm Management Devices Market, Global, Key Company Shares (%), 2010; Figure 10: Cardiac Rhythm Management Devices Market, Global, Key Company Revenues ($m), 2010; Figure 11: Interventional Cardiology Devices Market, Global, Revenue ($m), 2003-2010; Figure 12: Interventional Cardiology Devices Market, Global, Revenue ($m), 2010-2017; Figure 13: Interventional Cardiology Devices Market, Global, Key Company Shares (%), 2010; Figure 14: Peripheral Vascular Devices Market, Global, Revenue ($m), 2003-2010; Figure 15: Peripheral Vascular Devices Market, Global, Revenue ($m), 2010-2017; Figure 16: Peripheral Vascular Devices Market, Global, Key Company Shares (%), 2010; Figure 17: Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2003-2010; Figure 18: Cardiovascular Surgery Devices Market, Global, Revenue ($m), 2010-2017; Figure 19: Cardiovascular Surgery Devices Market, Global, Key Company Shares (%), 2010; Figure 20: Prosthetic Heart Valves Market, Global, Revenue ($m), 2003-2010; Figure 21: Prosthetic Heart Valves Market, Global, Revenue ($m), 2010-2017; Figure 22: Prosthetic Heart Valves Market, Global, Key Company Shares (%), 2010; Figure 23: External Defibrillators Devices Market, Global, Revenue ($m), 2003-2010; Figure 24: External Defibrillators Devices Market, Global, Revenue ($m), 2010-2017; Figure 25: External Defibrillators Devices Market, Global, Key Company Shares (%), 2010; Figure 26: Electrophysiology, Global, Revenue ($m), 2003-2010; Figure 27: Electrophysiology, Global, Revenue ($m), 2010-2017; Figure 28: Electrophysiology, Global, Key Company Shares (%), 2010; Figure 29: Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2003-2010; Figure 30: Cardiovascular Monitoring and Diagnostic Devices Market, Global, Revenue ($m), 2010-2017; Figure 31: Cardiovascular Monitoring and Diagnostic Devices Market, Global, Key Company Shares (%), 2010; Figure 32: Cardiac Assist Devices, Global, Market, Revenue ($m), 2003-2010; Figure 33: Cardiac Assist Devices, Global, Market, Revenue ($m), 2010-2017; Figure 34: Cardiac Assist Devices Market, Global, Key Company Shares (%), 2010; Figure 35: Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2003-2010; Figure 36: Cardiovascular Prosthetic Devices Market, Global, Revenue ($m), 2010-2017; Figure 37: Cardiovascular Prosthetic Devices Market, Global, Key Company Shares (%), 2010; Figure 38: Cardiovascular Devices Market, Global, Cross Country Analysis, CAGR (%), 2003-2017; Figure 39: Cardiovascular Devices Market, The US, Revenue ($m), 2003-2010; Figure 40: Cardiovascular Devices Market, The US, Revenue ($m), 2010-2017; Figure 41: Cardiovascular Devices Market, Canada, Revenue ($m), 2003-2010; Figure 42: Cardiovascular Devices Market, Canada, Revenue ($m), 2010-2017; Figure 43: Cardiovascular Devices Market, The UK, Revenue ($m), 2003-2010; Figure 44: Cardiovascular Devices Market, The UK, Revenue ($m), 2010-2017; Figure 45: Cardiovascular Devices Market, Germany, Revenue ($m), 2003-2010; Figure 46: Cardiovascular Devices Market, Germany, Revenue, ($m), 2010-2017; Figure 47: Cardiovascular Devices Market, France, Revenue ($m), 2003-2010; Figure 48: Cardiovascular Devices Market, France, Revenue $m), 2010-2017; Figure 49: Cardiovascular Devices Market, Italy, Revenue ($m), 2003-2010; Figure 50: Cardiovascular Devices Market, Italy, Revenue ($m), 2010-2017; Figure 51: Cardiovascular Devices Market, Spain, Revenue ($m), 2003-2010; Figure 52: Cardiovascular Devices Market, Spain, Revenue, ($m), 2010-2017; Figure 53: Cardiovascular Devices Market, Japan, Revenue ($m), 2003-2010; Figure 54: Cardiovascular Devices Market, Japan, Revenue, ($m), 2010-2017; Figure 55: Cardiovascular Devices Market, China, Revenue ($m), 2003-2010; Figure 56: Cardiovascular Devices Market, China, Revenue, ($m), 2010-2017; Figure 57: Cardiovascular Devices Market, India, Revenue ($m), 2003-2010; Figure 58: Cardiovascular Devices Market, India, Revenue ($m), 2010-2017; Figure 59: Cardiovascular Devices Market, Australia, Revenue ($m), 2003-2010; Figure 60: Cardiovascular Devices Market, Australia, Revenue ($m), 2010-2017; Figure 61: Cardiovascular Devices Market, Brazil, Revenue ($m), 2003-2010; Figure 62: Cardiovascular Devices Market, Brazil, Revenue ($m), 2010-2017; Figure 63: Cardiovascular Devices Market, Global, Competitive Assessment; Figure 64: Interventional Cardiology Market, Global, Pipeline Products Summary, 2011; Figure 65: Peripheral Vascular Devices Market, Global, Pipeline Products Summary, 2011; Figure 66: Cardiac Monitoring and Diagnostic Devices Market, Global, Pipeline Products Summary, 2011; Figure 67: Cardiac Assist Devices Market, Global, Pipeline Products Summary, 2011; Figure 68: Electrophysiology Market, Global, Pipeline Products Summary, 2011; Figure 69: Prosthetic Heart Valves Market, Global, Pipeline Products Summary, 2011; Figure 70: Cardiovascular Surgery Devices Market, Global, Pipeline Products Summary, 2011; Figure 71: Cardiac Rhythm Management Market, Global, Pipeline Products Summary, 2011; Figure 72: Cardiovascular Prosthetic Devices Market, Global, Pipeline Products Summary, 2011; Figure 73: Cardiovascular Devices Market, Mergers and Acquisitions, Number of Deals, Global, 2007-2010

Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth

Share this report

Other tasks

Research Assistance

Related Markets

Minimally Invasive Surgery Reports

Free Alert Me service